OUR FOCUS
Harnessing Transformative Trends
From advanced imaging systems to wearable devices and telemedicine platforms, Medical Technology’s boundaries are blurring with other subsectors to play a central role in improving patient outcomes and healthcare delivery.
Our Medical Technology team supports both emerging and established companies, serving as a valued partner through M&A, capital raising, and strategic transactions.
Recent transactions
$50 Million
Sole Agent
At-the-Market Facility
March 2025
$350 Million
Joint Bookrunner
Rule 144A Convertible Senior Notes Offering
March 2025
$65 Million
Joint Bookrunner
Follow-On
February 2025
$204 Million
Joint Lead Bookrunner
Initial Public Offering
January 2025
Featured Insights
Podcasts
December 2025
David Hong, MD, Steve Potts, PhD, MBA, and Vivek Subbiah, MD talk Pan-Tumor Approvals in a Post-IRA World
Featured Research
December 2025
Biopharma / ACR 2025 Takeaways: Cell Therapy and T-cell Engager Excitement Grows
Articles
October 2025
